| # | Drug | Count |
|---|---|---|
| 0 | CABOZANTINIB | 4 |
| 1 | BEVACIZUMAB | 3 |
| 2 | METFORMIN | 3 |
| 3 | METFORMIN ER 500 MG | 3 |
| 4 | METFORMIN ER 750 MG | 3 |
| 5 | ATEZOLIZUMAB | 2 |
| 6 | ADALIMUMAB | 1 |
| 7 | ADALIMUMAB-AATY | 1 |
| 8 | ADALIMUMAB-ADAZ | 1 |
| 9 | ADALIMUMAB-FKJP | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| 1 | CABOZANTINIB | 4 | 0.0001 |
| 2 | ATEZOLIZUMAB | 2 | 0.0001 |
| 3 | CETUXIMAB | 1 | 0.0000 |
| 4 | PEMETREXED DISODIUM | 1 | 0.0000 |
| 5 | BEVACIZUMAB | 3 | 0.0000 |
| 6 | IPILIMUMAB | 1 | 0.0000 |
| 7 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 8 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 9 | GEMCITABINE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |
| 9 | Corticosteroid [EPC] | 1 | 0.0000 |